Resmed Acquires Noctrix Health to Enter Restless Legs Syndrome Market
The acquisition adds the FDA-cleared, non-pharmacologic Nidra TOMAC therapy to Resmed’s portfolio, expanding its reach into the treatment of restless legs syndrome.
Read More
Author: SR Edit Staff
FDA Clears Next-Gen Mandibular Jaw Movement Tech HST
The new rechargeable home sleep test integrates more sensors than the original, including thermistors, an optical module, and a mic.
Read More
Which Patients Benefit Most from Tirzepatide for Obesity & OSA?
New research identifies a “strong response endotype” of patients who experience nearly double the sleep apnea improvement from tirzepatide.
Read More
Nexalin Acquires Digital Health Platform Ahead of FDA Pivotal Trial for Insomnia Treatment
The acquisition of PONM gives Nexalin ownership of the AI-integrated software supporting its HALO Clarity program, preparing for a 160-participant trial for moderate-to-severe insomnia.
Read More
Even Slight Changes in Skin Temp Can Trigger Cataplexy
The brain has neuronal systems that respond to skin temperature. In narcolepsy, these systems act as a switch, determining whether the brain enters REM sleep or triggers muscle paralysis while the person is awake.
Read More